MiNK Therapeutics (INKT) Stock Chart & Stock Price History $14.10 +0.01 (+0.04%) As of 11:15 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MiNK Therapeutics Stock Price Performance The MiNK Therapeutics (INKT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 107.28%, with a year-to-date return of 102.25%. In the past month, the stock has decreased 2.12%, reflecting recent market activity. As of the latest close, MiNK Therapeutics traded at $14.09 with a market cap of $63.69 million and volume of 17,629 shares. Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-3.13%1 Month Performance-2.12%3 Month Performance-65.29%Year-To-Date Performance+102.25%1 Year Performance+107.28% INKT Stock Chart for Tuesday, October, 14, 2025 INKT Chart by TradingView MiNK Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/13/2025$14.00$14.09+0.64%$14.49$13.9517,629 shs$63.69 million10/10/2025$14.55$14.00-3.78%$14.85$13.8537,220 shs$63.28 million10/09/2025$14.59$14.55-0.27%$15.00$14.5439,129 shs$65.81 million10/08/2025$14.90$14.59-2.08%$15.35$14.3231,703 shs$65.95 million10/07/2025$15.19$14.90-1.91%$15.18$14.1037,810 shs$67.35 million10/06/2025$15.02$15.19+1.13%$16.00$14.9432,852 shs$68.70 million10/03/2025$15.46$15.02-2.85%$15.42$14.5631,417 shs$67.94 million10/02/2025$14.66$15.46+5.46%$15.55$14.3037,055 shs$69.88 million10/01/2025$14.00$14.66+4.71%$14.98$13.5536,978 shs$66.26 million09/30/2025$13.70$14.00+2.19%$14.05$13.5336,699 shs$63.32 million Get the Latest News and Ratings for INKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/29/2025$13.96$13.70-1.86%$14.39$13.7021,579 shs$61.92 million09/26/2025$13.61$13.96+2.57%$14.80$13.6258,661 shs$63.10 million09/25/2025$14.34$13.61-5.09%$14.92$13.6144,411 shs$61.52 million09/24/2025$14.92$14.34-3.89%$15.37$14.3224,518 shs$64.82 million09/23/2025$16.30$14.92-8.47%$16.84$14.8255,053 shs$67.44 million09/22/2025$15.09$16.30+8.02%$16.98$15.05113,821 shs$73.68 million09/19/2025$15.35$15.09-1.69%$15.92$14.6244,184 shs$68.21 million09/18/2025$14.24$15.35+7.79%$15.58$14.4142,464 shs$69.38 million09/17/2025$14.59$14.24-2.40%$15.09$14.2432,653 shs$64.41 million09/16/2025$14.27$14.59+2.24%$14.68$14.0022,097 shs$65.95 million09/15/2025$14.40$14.27-0.90%$14.51$14.0028,693 shs$64.50 million Related Companies Future FinTech Group Stock Chart Lunai Bioworks Stock Chart Sagimet Biosciences Stock Chart Atea Pharmaceuticals Stock Chart Maxpro Capital Acquisition Stock Chart Humacyte Stock Chart Lifecore Biomedical Stock Chart Cartesian Therapeutics Stock Chart Adherex Technologies Stock Chart Tiziana Life Sciences Stock Chart Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INKT) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
